Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated Statements of Shareholders??? Equity

v3.25.1
Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance at Dec. 31, 2021 $ 4,664 $ 114,223 $ (969) $ (72,797) $ 45,121
Balance (in Shares) at Dec. 31, 2021 10,722,024        
Exercise of warrants $ 191 1,509 1,700
Exercise of warrants (in Shares) 425,000        
Exercise of options $ 18 156 174
Exercise of options (in Shares) 39,457        
Share-based compensation 2,211 2,211
Net loss (16,925) (16,925)
Balance at Dec. 31, 2022 $ 4,873 118,099 (969) (89,722) 32,281
Balance (in Shares) at Dec. 31, 2022 11,186,481        
Exercise of warrants $ 76 668 744
Exercise of warrants (in Shares) 186,000        
Exercise of options $ 33 331 364
Exercise of options (in Shares) 80,191        
Share-based compensation 1,970 1,970
Net loss (7,019) (7,019)
Balance at Dec. 31, 2023 $ 4,982 121,068 (969) (96,741) $ 28,340
Balance (in Shares) at Dec. 31, 2023 11,452,672       11,452,672
Exercise of options $ 1 8 $ 9
Exercise of options (in Shares) 1,840       1,840
Share-based compensation 1,725 $ 1,725
Net loss (16,609) (16,609)
Balance at Dec. 31, 2024 $ 4,983 $ 122,801 $ (969) $ (113,350) $ 13,465
Balance (in Shares) at Dec. 31, 2024 11,454,512       11,454,512